A new biocatalyst for chiral amine synthesis could 'significantly improve' industrial production of the one of the world's best selling diabetes therapies
One route to developing new drugs is to look at targeting the hundreds of G-protein-coupled receptors that are not currently exploited clinically. Clare Sansom investigates
Scientist Michael Brooks stood for parliament at the last election against an MP who favours homeopathy and medical astrology. He lost. Should we worry?
School children in the UK are told oil will run out by 2050, but oil companies expect production to be about the same as it is today, writes Richard Pike
Organic chemist Joe Sweeney is developing a collaborative network with industry that looks set to provide a new model for knowledge and innovation exchange, says Sarah Houlton
Age is no barrier to career progression. Just stay up to date, re-jig your CV and brush up on the latest interview techniques before making your move, says Caroline Tolond
Graduates of a dual degree programme in agricultural science run by Cornell University and Tamil Nadu Agricultural University will have a lot of mouths to feed, writes Matt Brown
